GLUL, ALDH1A1, and S100β were also relatively highly expressed in GPC2 tumors, but were marginally insignificant (Fig. 4a ).
← all excerpts
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
1
—
—